Preliminary results of the LUMINANCE trial

Exciting preliminary results from the LUMINANCE study were presented at the ELCC 2023 conference. The phase 3b, single-arm study investigated the efficacy of durvalumab + platinum-etoposide in patients with extensive-stage SCLC. MediMix interviewed the lead investigator, Prof Niels Reinmuth from the Asklepios Lung Clinic in Munich-Gauting, Germany on this promising findings.